AnnJi Pharmaceutical Co. Ltd
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy's Disease 2025-10-23 11:24
AnnJi Showcases Clinical Breakthrough of AJ201 at WMS 2025 2025-10-13 16:03
AnnJi Pharmaceutical Company Announces Positive Phase 1/2a Results for AJ201 in Spinal and Bulbar Muscular Atrophy (SBMA) Patients 2025-05-22 09:21
1